Literature DB >> 23269010

Highly resolved two-dimensional ¹H spectroscopy of the human brain using ISIS CT-PRESS with resolution enhancement.

Hidehiro Watanabe1, Nobuhiro Takaya, Fumiyuki Mitsumori.   

Abstract

In constant time (CT) point-resolved spectroscopy (PRESS), echo centers shift with the fast decay of short T₂* on two-dimensional (2D) time domain (TD) data under inhomogeneous B₀ field like in vivo conditions. Though ¹H decoupling along the F₁ direction is a feature of this method, the tilted and broadened peak pattern on the F₁-F₂ plane after reconstruction causes the peaks to overlap. To enhance resolution to achieve highly resolved 2D CT-PRESS spectra in the human brain, we propose a 2-part window function that comprises an enhancement part for shifting echoes with fast decay and a conventional part, such as Lorentzian, Gaussian, or sine-bell function. We obtained 2D spectra from human brains at 4.7T. The 3 diagonal peaks of C4H of glutamate (Glu C4H) at 2.35 ppm, C2H of γ-amino butyric acid (GABA C2H) at 2.28 ppm, and C4H of glutamine (Gln C4H) at 2.44 ppm-overlapped on the spectra processed with the conventional window but clearly resolved on the spectra using the proposed enhancement window. The signal-to-noise ratio per unit measurement time of Glu C4H on a CT-PRESS spectrum of the human brain was 1.7 times higher than that on a spectrum obtained by CT-correlation spectroscopic (COSY). In conclusion, 2D CT-PRESS spectra processed with the proposed window function to enhance resolution can resolve peaks of coupled ¹H spins with higher accuracy and sensitivity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23269010     DOI: 10.2463/mrms.11.235

Source DB:  PubMed          Journal:  Magn Reson Med Sci        ISSN: 1347-3182            Impact factor:   2.471


  1 in total

1.  Neonatal brain metabolite concentrations: an in vivo magnetic resonance spectroscopy study with a clinical MR system at 3 Tesla.

Authors:  Moyoko Tomiyasu; Noriko Aida; Mamiko Endo; Jun Shibasaki; Kumiko Nozawa; Eiji Shimizu; Hiroshi Tsuji; Takayuki Obata
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.